Brief: Circio Presents Groundbreaking In Vivo Data
26/02/2026 06:28
Feb 26 (Reuters) - Circio Holding ASA CRNA.OL: AAV-CIRCVEC 4.0 OUTPERFORMS MRNA-BASED AAV BY UP TO 50-FOLD Source text: ID:nMFN9pvbNs Further company coverage: CRNA.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration